Current Screening Tests/Biomarkers for Alzheimer's Disease: Implications for Clinicians.
作者信息
Patel Vimita, Grossberg George
机构信息
Resident in the Department of Psychiatry and Behavioral Neuroscience.
Henry and Amelia Nasrallah Professor, and Director, Division of Geriatric Psychiatry, Department of Psychiatry and Behavioral Neuroscience, Saint Louis University School of Medicine, St. Louis, Missouri.
出版信息
Mo Med. 2024 Jul-Aug;121(4):271-275.
Abstract
摘要
相似文献
1
Current Screening Tests/Biomarkers for Alzheimer's Disease: Implications for Clinicians.目前用于阿尔茨海默病的筛查测试/生物标志物：对临床医生的启示
Mo Med. 2024 Jul-Aug;121(4):271-275.
2
Relationship of dementia screening tests with biomarkers of Alzheimer's disease.痴呆症筛查测试与阿尔茨海默病生物标志物的关系。
Brain. 2010 Nov;133(11):3290-300. doi: 10.1093/brain/awq204. Epub 2010 Sep 7.
3
When is Alzheimer's not dementia-Cochrane commentary on The National Institute on Ageing and Alzheimer's Association Research Framework for Alzheimer's Disease.当阿尔茨海默病不是痴呆症时——对美国国家老龄化研究所和阿尔茨海默病协会阿尔茨海默病研究框架的评论。
Age Ageing. 2019 Mar 1;48(2):174-177. doi: 10.1093/ageing/afy167.
4
Current opinion neurology: visual pathway biomarkers in Alzheimer's disease.当代神经病学观点：阿尔茨海默病的视觉通路生物标志物。
Curr Opin Neurol. 2020 Feb;33(1):79-86. doi: 10.1097/WCO.0000000000000788.
5
REAL AD-Validation of a realistic screening approach for early Alzheimer's disease.REAL 验证：一种用于早期阿尔茨海默病的现实筛查方法。
Alzheimers Dement. 2024 Nov;20(11):8172-8182. doi: 10.1002/alz.14219. Epub 2024 Sep 23.
6
Language and Meaning: Asymptomatic Alzheimer's Disease in the Clinic and Society.语言与意义：临床与社会中的无症状阿尔茨海默病
J Alzheimers Dis. 2024;99(2):489-492. doi: 10.3233/JAD-240195.
7
The ROSAS Cohort: A Prospective, Longitudinal Study of Biomarkers for Alzheimer's Disease. Strategy, Methods and Initial Results.ROSAS 队列：阿尔茨海默病生物标志物的前瞻性纵向研究。策略、方法和初步结果。
J Prev Alzheimers Dis. 2017;4(3):183-193. doi: 10.14283/jpad.2017.8.
8
Challenges in the practical implementation of blood biomarkers for Alzheimer's disease.阿尔茨海默病血液生物标志物实际应用中的挑战。
Lancet Healthy Longev. 2024 Oct;5(10):100630. doi: 10.1016/j.lanhl.2024.07.013. Epub 2024 Oct 3.
9
CSF tau and the CSF tau/ABeta ratio for the diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).脑脊液tau蛋白及脑脊液tau蛋白与β淀粉样蛋白比值在轻度认知障碍（MCI）患者中用于诊断阿尔茨海默病性痴呆及其他痴呆。
Cochrane Database Syst Rev. 2017 Mar 22;3(3):CD010803. doi: 10.1002/14651858.CD010803.pub2.
10
Plasma biomarkers and genetics in the diagnosis and prediction of Alzheimer's disease.血浆生物标志物和遗传学在阿尔茨海默病的诊断和预测中的应用。
Brain. 2023 Feb 13;146(2):690-699. doi: 10.1093/brain/awac128.
本文引用的文献
1
APOE4 homozygozity represents a distinct genetic form of Alzheimer's disease.载脂蛋白 E4 纯合子代表一种独特的阿尔茨海默病遗传形式。
Nat Med. 2024 May;30(5):1284-1291. doi: 10.1038/s41591-024-02931-w. Epub 2024 May 6.
2
Clinical validation of the PrecivityAD2 blood test: A mass spectrometry-based test with algorithm combining %p-tau217 and Aβ42/40 ratio to identify presence of brain amyloid.PrecivityAD2 血液检测的临床验证：一种基于质谱的检测方法，采用 %p-tau217 和 Aβ42/40 比值相结合的算法来识别脑淀粉样蛋白的存在。
Alzheimers Dement. 2024 May;20(5):3179-3192. doi: 10.1002/alz.13764. Epub 2024 Mar 16.
3
Lecanemab in Early Alzheimer's Disease.早期阿尔茨海默病中的lecanemab
N Engl J Med. 2023 Jan 5;388(1):9-21. doi: 10.1056/NEJMoa2212948. Epub 2022 Nov 29.
4
Plasma and CSF biomarkers in a memory clinic: Head-to-head comparison of phosphorylated tau immunoassays.在记忆诊所中进行的血浆和脑脊液生物标志物检测：磷酸化tau 免疫分析的头对头比较。
Alzheimers Dement. 2023 May;19(5):1913-1924. doi: 10.1002/alz.12841. Epub 2022 Nov 12.
5
The AHEAD 3-45 Study: Design of a prevention trial for Alzheimer's disease.AHEAD 3-45 研究：阿尔茨海默病预防试验设计。
Alzheimers Dement. 2023 Apr;19(4):1227-1233. doi: 10.1002/alz.12748. Epub 2022 Aug 15.
6
Plasma p-tau231 and p-tau217 as state markers of amyloid-β pathology in preclinical Alzheimer's disease.血浆 p-tau231 和 p-tau217 作为临床前阿尔茨海默病淀粉样β病理的状态标志物。
Nat Med. 2022 Sep;28(9):1797-1801. doi: 10.1038/s41591-022-01925-w. Epub 2022 Aug 11.
7
P-tau217 in Alzheimer's disease.阿尔茨海默病中的 P-tau217。
Clin Chim Acta. 2022 Jun 1;531:100-111. doi: 10.1016/j.cca.2022.03.018. Epub 2022 Mar 24.
8
Overview of tau PET molecular imaging.tau蛋白正电子发射断层扫描分子成像概述。
Curr Opin Neurol. 2022 Apr 1;35(2):230-239. doi: 10.1097/WCO.0000000000001035.
9
Changes in retinal microvasculature and retinal layer thickness in association with apolipoprotein E genotype in Alzheimer's disease.阿尔茨海默病患者载脂蛋白 E 基因型与视网膜微血管和视网膜层厚度变化的关系。
Sci Rep. 2021 Jan 19;11(1):1847. doi: 10.1038/s41598-020-80892-z.
10
High-precision plasma β-amyloid 42/40 predicts current and future brain amyloidosis.高精度血浆β-淀粉样蛋白 42/40 可预测当前和未来的脑淀粉样变。
Neurology. 2019 Oct 22;93(17):e1647-e1659. doi: 10.1212/WNL.0000000000008081. Epub 2019 Aug 1.
Zotero 插件